Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Bicalutamide improved hair growth more than spironolactone in women with hair loss.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

CG2001 is safe and well-tolerated for treating hair loss in men.

PRP treatment helps hair growth and density in androgenetic alopecia patients.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

WYE-130600 may cause skin thickening and irritation.

Using fractional CO2 laser with halometasone cream works better for chronic hand eczema than just the cream, improving symptoms and quality of life with fewer relapses.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Cervi Parvum Cornu complex improved urinary symptoms in men without major side effects.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Fat grafting is safe and effective in both active and stable phases of localized scleroderma.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Baricitinib is effective and safe for treating severe alopecia areata.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.